Stockreport

Actuate to Participate in Lantern's Pharma Webinar on AI-Driven Drug Development [Yahoo! Finance]

Lantern Pharma Inc.  (LTRN) 
PDF CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceuti [Read more]